Canada markets closed

RespireRx Pharmaceuticals Inc. (RSPI)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0010+0.0001 (+11.11%)
At close: 03:39PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
Operating Expenses
Research Development
313.245
429.532
702.043
638.275
Selling General and Administrative
1,095
1,150
1,857
2,677
Total Operating Expenses
1,408
1,579
2,559
3,315
Operating Income or Loss
-1,408
-1,579
-2,559
-3,315
Interest Expense
435.735
603.818
724.769
545.675
Total Other Income/Expenses Net
47.297
80.453
139.057
-440.401
Income Before Tax
-1,796
-2,103
-3,145
-4,301
Income from Continuing Operations
-1,796
-2,103
-3,145
-4,301
Net Income
-1,796
-2,103
-3,145
-4,301
Net Income available to common shareholders
-2,171
-3,973
-3,523
-5,741
Basic EPS
-0.02
-0.04
-0.04
-0.02
Diluted EPS
-0.02
-0.04
-0.04
-0.02
Basic Average Shares
173,892
111,323
88,347
258,557
Diluted Average Shares
173,892
111,323
88,347
258,557